If we don’t incentivize continued investments in drug research and development, we’ll lose out on new therapies that don’t ...

Experts decried potential rescissions of funding for science agencies as well as cuts to government researchers and grants.

Health insurer Humana is scaling back the number of medical services subject to prior approval and speeding up decisions ...